Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Hamacher

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2021
Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial AnalysisLukas Kessler, Justin Ferdinandus, Nader Hirmas, et al.
Annals of Surgical Oncology|May 13, 2022
Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of MetastasectomyTheresa Stork, Balazs Hegedüs, Wiebke Guder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 20, 2025
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT of Patients with Gastrointestinal Stromal Tumors in Comparison to 2-[<sup>18</sup>F]FDG PET/CT and Contrast-Enhanced CT: Results from a Prospective Observational StudyTimo Bartel, Kim M Pabst, Christina Barg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot studyKim M Pabst, Riccardo Mei, Katharina Lückerath, et al.
Applied Psychophysiology and Biofeedback|November 19, 2022
Cancer Patients' Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy: A Clinical Waitlist Control StudyKira Schmidt, Marvin Krawutschke, Axel Kowalski, et al.
Journal of Cancer Research and Clinical Oncology|November 13, 2024
Prognostic factors in clear cell sarcoma: an analysis of soft tissue sarcoma in 43 casesJanik Grothues, Jendrik Hardes, Abbas Agaimy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2021
<sup>68</sup>Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the <sup>68</sup>Ga-FAPI PET Prospective Observational TrialLukas Kessler, Justin Ferdinandus, Nader Hirmas, et al.
Cancers|November 26, 2022
Plasma Sequencing for Patients with GIST-Limitations and Opportunities in an Academic SettingJohanna Falkenhorst, Susanne Grunewald, Dawid Krzeciesa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
Sarcoma|September 21, 2021
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and EtiologyInna Schott, Sven-Thorsten Liffers, Farhad Farzaliyev, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2021
Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial AnalysisLukas Kessler, Justin Ferdinandus, Nader Hirmas, et al.
Annals of Surgical Oncology|May 13, 2022
Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of MetastasectomyTheresa Stork, Balazs Hegedüs, Wiebke Guder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 20, 2025
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT of Patients with Gastrointestinal Stromal Tumors in Comparison to 2-[<sup>18</sup>F]FDG PET/CT and Contrast-Enhanced CT: Results from a Prospective Observational StudyTimo Bartel, Kim M Pabst, Christina Barg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot studyKim M Pabst, Riccardo Mei, Katharina Lückerath, et al.
Applied Psychophysiology and Biofeedback|November 19, 2022
Cancer Patients' Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy: A Clinical Waitlist Control StudyKira Schmidt, Marvin Krawutschke, Axel Kowalski, et al.
Journal of Cancer Research and Clinical Oncology|November 13, 2024
Prognostic factors in clear cell sarcoma: an analysis of soft tissue sarcoma in 43 casesJanik Grothues, Jendrik Hardes, Abbas Agaimy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2021
<sup>68</sup>Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the <sup>68</sup>Ga-FAPI PET Prospective Observational TrialLukas Kessler, Justin Ferdinandus, Nader Hirmas, et al.
Cancers|November 26, 2022
Plasma Sequencing for Patients with GIST-Limitations and Opportunities in an Academic SettingJohanna Falkenhorst, Susanne Grunewald, Dawid Krzeciesa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
Sarcoma|September 21, 2021
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and EtiologyInna Schott, Sven-Thorsten Liffers, Farhad Farzaliyev, et al.
Pageof 7